| Market Capitalization (Millions $) |
50,833 |
| Shares
Outstanding (Millions) |
275 |
| Employees |
72,000 |
| Revenues (TTM) (Millions $) |
20,840 |
| Net Income (TTM) (Millions $) |
941 |
| Cash Flow (TTM) (Millions $) |
291 |
| Capital Exp. (TTM) (Millions $) |
585 |
Business Description
Becton, Dickinson and Company (BD) is a prominent global medical technology company that focuses on manufacturing and selling a wide range of medical supplies, devices, laboratory equipment, and diagnostic products. Its offerings cater to healthcare institutions, life science researchers, clinical laboratories, industry professionals, and the general public.
Business Segments
BD operates through three main business segments:
1. BD Medical: This segment encompasses various medical products, including:
- Hypodermic syringes and needles for injections.
- Insulin syringes and pen needles, as well as blood glucose monitoring systems for diabetes management.
- Infusion therapy devices, prefillable drug delivery systems, surgical instruments (blades and scalpels), and critical care systems.
- Specialty items such as anesthesia needles, ophthalmic surgery instruments, elastic support products, and thermometers.
2. BD Diagnostics: This segment focuses on diagnostics and includes:
- Clinical and industrial microbiology products.
- Sample collection and specimen management systems.
- Molecular diagnostic instruments and immunodiagnostic test kits.
- Consulting services aimed at optimizing laboratory operations.
3. BD Biosciences: This segment delivers products and systems for life sciences applications, featuring:
- Flow cytometry systems for cell analysis.
- Monoclonal antibodies aimed at biomedical research.
- Molecular biology tools for studying genes and their functions, as well as cell growth and screening solutions.
- Laboratory consumables and equipment.
International Operations
BD has a robust global presence, selling products in various regions, including Europe, Japan, Asia Pacific, Canada, and Latin America. Key products in international markets mirror those in the U.S. with a significant focus on:
- Hypodermic needles and syringes.
- Insulin syringes and pen needles.
- Diagnostic systems.
- Blood collection products (e.g. VACUTAINER® brand).
- Prefillable syringe systems (e.g. HYPAK® brand) and infusion therapy devices.
The company maintains manufacturing facilities in multiple countries, including Brazil, China, Germany, India, Japan, and the United Kingdom. However, BD acknowledges that foreign economic conditions and exchange rate fluctuations can affect the profitability of its international operations. Operating in certain countries may present risks related to local economic policies and political uncertainties.
Competition
BD faces competition from a range of specialized companies within the medical technology sector. Competitive dynamics vary across different product lines, with factors such as pricing, quality, service, brand reputation, distribution capabilities, and promotional strategies influencing market share. To maintain a competitive edge, BD invests in research, quality management, innovation, and productivity improvements across its operations.
In summary, Becton, Dickinson and Company operates as a comprehensive provider of medical technologies, supported by diverse product offerings and a significant international footprint, while navigating competitive challenges and global market dynamics.
Company Address: 1 Becton Drive, Franklin Lakes, 7417 NJ
Company Phone Number: 847-6800 Stock Exchange / Ticker: NYSE BDX
|
2.05% 
98.7 %